Abstract
The partial area method was investigated for evaluation of equivalency in the rate of absorption of immediate release formulations. The applicability of the method was demonstrated with four drugs with different pharmacokinetic/pharmacodynamic characteristics. The confidence interval approach currently employed for bioequivalence determinations was applied to the relevant absorption parameters, including C max and partial AUCs. The method was found to be more discriminating than C max and/or T max in the evaluation of the absorption rate of drugs. The cutoff time or point for partial AUC calculation may vary with the type of drug under study, depending on its clinical use and onset of action. The method was shown to be useful in the assessment of rate of absorption in bioequivalence studies.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
K. Khoo, M. Gibaldi, and R. K. Brazzell. Comparison of statistical moment parameters to Cmax and Tmax for detecting differences in in vivo dissolution rates. J. Pharm. Sci. 74(12):1340–1342 (1985).
A. J. Jackson and M.-L. Chen. Application of moment analysis in assessing rates of absorption for bioequivalency studies. J. Pharm. Sci. 76(l):6–9 (1987).
L. Aarons. Assessment of rate of absorption in bioequivalence studies. J. Pharm. Sci. 76(10):853–855 (1987).
P. Veng-Pedersen and L. G. Tillman. Center of gravity of drug level curves: A model-independent parameter useful in bioavailability studies. J. Pharm. Sci. 78(10):848–854 (1989).
Proceedings of Bio-International '89—Issues in the Evaluation of Bioavailability Data Session 1. Rate of Absorption in Bioequivalency Determinations, Toronto, Canada, Oct. 1–4, 1989.
M.-L. Chen. Assessment of Rate of Absorption in Bioequivalence Studies U.S. Food and Drug Administration, Generic Drugs Advisory Committee Meeting, Bethesda, MD, Sept. 26–27, 1991.
S. E. Rosenbaum, C. T. Rhodes, and C. Bon. Area under the curve estimation in bioequivalence studies. Drug Dev. Ind. Pharm. 16(1):157–163 (1990).
Antibiotic Residues in Milk, Dairy Products and Animal Tissues: Methods, Reports and Protocols U.S. Department of Health, Education and Welfare, Food and Drug Administration, Washington, DC, 1968, Part 1, Sect. 2, pp. 12–27.
J. L. Shimek, N. G. Rao, and S. K. Khalil. High-pressure liquid chromatographic determination of ibuprofen in plasma. J. Pharm. Sci. 70(5):514–516 (1980).
S. Sved, I. J. McGilveray, and N. Beaudoin. Assay of sulfonylureas in human plasma by high-performance liquid chromatography. J. Pharm. Sci. 65:1356 (1976).
S. I. Ankier, B. K. Martin, M. S. Rogers, P. K. Carpenter, and C. Graham. Trazodone—A new assay procedure and some pharmacokinetic parameters. Br. J. Clin. Pharmacol. 11:505–509 (1981).
M. Gibaldi and D. Perrier. Pharmacokinetics Marcel Dekker, New York, 1982.
D. J. Schuirmann. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J. Pharmacokin. Biopharm. 15:657–680 (1987).
S. L. Nightingale and J. C. Morrison, Generic drugs and the prescribing physicians. JAMA 258(9):1200–1204 (1987).
A. J. Romero, C. Bon, E. Johnson, S. E. Rosenbaum, and C. T. Rhodes. Use and limitations of the truncated area under the curve in bioequivalence testing. Clin. Res. Prac. Drug Reg. Affairs 8(2):123–151 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chen, ML. An Alternative Approach for Assessment of Rate of Absorption in Bioequivalence Studies. Pharm Res 9, 1380–1385 (1992). https://doi.org/10.1023/A:1015842425553
Issue Date:
DOI: https://doi.org/10.1023/A:1015842425553